Watson Danielle
Transaction: 07/07/2026
BUY
Change
+25,000
Price
Not reported
Filing
07/09/2026
Type
BUY
HeartSciences Inc.
HSCS • Medical - Devices
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jan 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$5.29M
Growth
9.9%
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 67.5%Positive free cash flow · 0.36High debt level · 17.41Weak liquidity · 0.53Weak profitability
Financial data as of: Jan 31, 2026, 12:00 AM UTCLast earnings update: Mar 16, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$5.29M
52W Range1.63 - 4.30
Beta1.79
Gross Margin32.45%
Oper. Margin-18.36%
Profit Margin-14.16%
Debt/Eq17.41
Current Ratio0.53
Quick Ratio0.40
Revenue 5Y9.88%
Price$0.00
Change0.00%
Market Cap$5.29M
52W Range1.63 - 4.30
Beta1.79
Gross Margin32.45%
Oper. Margin-18.36%
Profit Margin-14.16%
Debt/Eq17.41
Current Ratio0.53
Quick Ratio0.40
Revenue 5Y9.88%
Target$3.00
Target Median$3.00
Target Range3.00 - 3.00
Volume36.19K
Avg Volume2.34M
EPS Surprise0.21
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
76/100
Why this score▼
Positive revenue growth · 67.5%Positive free cash flow · 0.36High debt level · 17.41Weak liquidity · 0.53Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-07-24
Low
$3.00
Mean
$3.00
Median
$3.00
High
$3.00
Financial Health
Score4 / 20
Debt / Equity: 17.41
Current Ratio: 0.53
Quick Ratio: 0.40
Status: HighRisk
Warnings
- High debt level
- Weak Liquidity
- Weak quick ratio
Insider Transactions
Recent executive and insider activity
Simpson Andrew
Transaction: 06/22/2026
BUY
Change
+425,000
Price
Not reported
Filing
06/24/2026
Type
BUY
Bent Bruce
Transaction: 01/12/2026
BUY
Change
+15,000
Price
Not reported
Filing
01/12/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Watson Danielle | BUY | +25,000 | Not reported | 07/07/2026 | 07/09/2026 |
| Simpson Andrew | BUY | +425,000 | Not reported | 06/22/2026 | 06/24/2026 |
| Bent Bruce | BUY | +15,000 | Not reported | 01/12/2026 | 01/12/2026 |
| Wells David R. | BUY | +15,000 | Not reported | 01/12/2026 | 01/12/2026 |
| Watson Danielle | BUY | +15,000 | Not reported | 12/22/2025 | 12/22/2025 |
| Szymczak Brian | BUY | +15,000 | Not reported | 12/22/2025 | 12/22/2025 |
| HILZ MARK T | BUY | +45,000 | Not reported | 12/22/2025 | 12/22/2025 |
| Simpson Andrew | BUY | +70,000 | $0.00 | 11/28/2025 | 11/28/2025 |
| HILZ MARK T | SELL | -4,416 | $3.54 | 07/29/2025 | 07/30/2025 |
| Bent Bruce | BUY | +25,000 | $4.37 | 07/09/2025 | 07/14/2025 |
| Watson Danielle | BUY | +25,000 | $4.37 | 07/09/2025 | 07/11/2025 |
| HILZ MARK T | BUY | +56,250 | Not reported | 07/09/2025 | 07/11/2025 |
| HILZ MARK T | BUY | +225,000 | $4.37 | 07/09/2025 | 07/11/2025 |
| Wells David R. | BUY | +25,000 | $4.37 | 07/09/2025 | 07/11/2025 |
| Simpson Andrew | BUY | +68,750 | Not reported | 07/09/2025 | 07/11/2025 |
| Simpson Andrew | BUY | +275,000 | $4.37 | 07/09/2025 | 07/11/2025 |
| Szymczak Brian | BUY | +25,000 | $4.37 | 07/09/2025 | 07/11/2025 |
| Bent Bruce | BUY | +6,000 | $3.33 | 01/16/2025 | 01/23/2025 |
| Simpson Andrew | BUY | +45,000 | $3.33 | 01/16/2025 | 01/21/2025 |
| Szymczak Brian | BUY | +6,000 | $3.33 | 01/16/2025 | 01/21/2025 |